Ionis Pharmaceuticals (NASDAQ:IONS) Upgraded to Hold at StockNews.com

StockNews.com upgraded shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) from a sell rating to a hold rating in a research report released on Saturday morning. Several other equities research analysts also recently weighed in on IONS. William Blair reissued an outperform rating on shares of Ionis Pharmaceuticals in a report on Monday, November 13th. […]

Leave a Reply

Your email address will not be published.

Previous post SigmaTron International (NASDAQ:SGMA) Coverage Initiated by Analysts at StockNews.com
Next post Peoples Bancorp (NASDAQ:PEBO) Upgraded at StockNews.com